Inogen Inc
$
71.13
0 (0%)
| Volume: | 387,341 | Avg Vol (1m): | 579,045 |
| Market Cap $: | 1.56 Bil | Enterprise Value $: | 1.32 Bil |
| P/E (TTM): | 34.64 | P/B: | 4.82 |
| Earnings Power Value | 25.9 |
| Net Current Asset Value | 11.34 |
| Tangible Book | 14.04 |
| Projected FCF | 26.61 |
| Median P/S Value | 107.56 |
| Graham Number | 25.51 |
| Peter Lynch Value | 33.72 |
| DCF (FCF Based) | 0 |
| DCF (Earnings Based) | 0 |
1Y (-%)
Manual of Stocks™ Web
Financial Strength : 9/10
GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| Current | vs industry | vs history | |
|---|---|---|---|
| Cash-to-Debt | No Debt |
Cash-To-Debt ranked
higher than
83.64%
of
330
companies
in the
Medical Devices
industry.
Industry Max: 504099, Med: 2.32, Min: -16.34
INGN:
No Debt
Ranked among companies with meaningful Cash-To-Debt only.
|
Cash-To-Debt range over the past 10 years
Min: 0.41, Med: 361.74, Max: 10000
Current: 10000
|
| Equity-to-Asset | 0.83 |
Equity-to-Asset ranked
higher than
81.23%
of
309
companies
in the
Medical Devices
industry.
Industry Max: 0.99, Med: 0.63, Min: -24.4
INGN:
0.83
Ranked among companies with meaningful Equity-to-Asset only.
|
Equity-to-Asset range over the past 10 years
Min: -1.7, Med: 0.82, Max: 0.85
Current: 0.83
|
| Interest Coverage | No Debt |
Interest Coverage ranked
higher than
83.02%
of
212
companies
in the
Medical Devices
industry.
Industry Max: 10000, Med: 66.37, Min: 0.03
INGN:
No Debt
Ranked among companies with meaningful Interest Coverage only.
|
Interest Coverage range over the past 10 years
Min: 1.68, Med: 684.14, Max: 10000
Current: 10000
|
| Piotroski F-Score | 7 |
0
1
2
3
4
5
6
7
8
9
| |
| Altman Z-Score | 16.53 |
DISTRESS
GREY
SAFE
| |
| Beneish M-Score | -2.17 |
Not Manipulator
Manipulator
| |
| WACC vs ROIC % |
ROIC 63.68%
WACC 13.56%
| ||
Profitability & Growth : 8/10
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
| Current | vs industry | vs history | |
|---|---|---|---|
| Operating Margin % | 9.22 |
Operating Margin ranked
higher than
72.44%
of
312
companies
in the
Medical Devices
industry.
Industry Max: 1148.46, Med: 1.96, Min: -47867.72
INGN:
9.22
Ranked among companies with meaningful Operating Margin only.
|
Operating Margin range over the past 10 years
Min: -5.62, Med: 9.41, Max: 11.27
Current: 9.22
|
| Net Margin % | 12.56 |
Net Margin ranked
higher than
71.79%
of
312
companies
in the
Medical Devices
industry.
Industry Max: 15538.12, Med: 1.4, Min: -45900
INGN:
12.56
Ranked among companies with meaningful Net Margin only.
|
Net Margin range over the past 10 years
Min: -6.54, Med: 7.86, Max: 33.71
Current: 12.56
|
| ROE % | 16.14 |
ROE ranked
higher than
73.03%
of
304
companies
in the
Medical Devices
industry.
Industry Max: 51.97, Med: 0.95, Min: -2921.66
INGN:
16.14
Ranked among companies with meaningful ROE only.
|
ROE range over the past 10 years
Min: 9.19, Med: 12.98, Max: 19.29
Current: 16.14
|
| ROA % | 13.23 |
ROA ranked
higher than
83.43%
of
332
companies
in the
Medical Devices
industry.
Industry Max: 1204.95, Med: -0.26, Min: -2520.55
INGN:
13.23
Ranked among companies with meaningful ROA only.
|
ROA range over the past 10 years
Min: -8.3, Med: 8.14, Max: 39.14
Current: 13.23
|
| ROC (Joel Greenblatt) % | 73.87 |
ROC (Joel Greenblatt) ranked
higher than
89.30%
of
327
companies
in the
Medical Devices
industry.
Industry Max: 8175, Med: 3.87, Min: -323166.67
INGN:
73.87
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
|
ROC (Joel Greenblatt) range over the past 10 years
Min: -13.45, Med: 29.92, Max: 93.23
Current: 73.87
|
| 3-Year Total Revenue Growth Rate | 31.10 |
3-Year Revenue Growth Rate ranked
higher than
86.61%
of
254
companies
in the
Medical Devices
industry.
Industry Max: 300.7, Med: 4.3, Min: -100
INGN:
27.5
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
|
3-Year Revenue Growth Rate range over the past 10 years
Min: 22.2, Med: 32, Max: 49.3
Current: 27.5
|
| 3-Year Total EBITDA Growth Rate | 21.60 |
3-Year EBITDA Growth Rate ranked
higher than
59.05%
of
232
companies
in the
Medical Devices
industry.
Industry Max: 109.5, Med: 7.5, Min: -344.2
INGN:
18.3
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
|
3-Year EBITDA Growth Rate range over the past 10 years
Min: 15.2, Med: 33.8, Max: 140.5
Current: 18.3
|
| 3-Year EPS w/o NRI Growth Rate | 60.10 |
3-Year EPS w/o NRI Growth Rate ranked
higher than
89.24%
of
223
companies
in the
Medical Devices
industry.
Industry Max: 241, Med: 7.8, Min: -413
INGN:
60.1
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
|
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 47.4, Max: 141
Current: 60.1
|
» INGN's 30-Y Financials
Financials (Next Earnings Date: 2019-08-07)
Guru Trades Click for details
Guru Trades in
SEC Filings
Gurus Latest Trades with NAS:INGN
» Interactive Chart
Peter Lynch Chart
Business Description
| Industry | Medical Devices » Medical Devices   NAICS : 325412   SIC : 3842 |
| Compare | NYSE:NVRO XSWX:MOVE TSE:3360 TSE:8086 SZSE:300633 XSWX:YPSN NAS:CNMD OCSE:OSSR NYSE:ITGR HKSE:00853 TSE:7817 TSE:6849 TSE:7575 NAS:CSII NAS:SILK SZSE:002317 NYSE:INSP XSWX:TECN NAS:SWAV SZSE:300326 |
| Traded in other countries | 6IO.Germany |
| Address | 326 Bollay Drive, Goleta, CA, USA, 93117 |
| Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. The majority of rental revenue comes from Medicare service reimbursement programs. Internationally, Inogen sells its products through distributors or large gas companies and home oxygen providers. Inogen generates the majority of its revenue in the United States. | |
Ratios
| Current | vs industry | vs history | |
|---|---|---|---|
| PE Ratio (TTM) | 34.64 |
PE Ratio ranked
lower than
93.33%
of
180
companies
in the
Medical Devices
industry.
Industry Max: 8940, Med: 30.17, Min: 0.06
INGN:
34.64
Ranked among companies with meaningful PE Ratio only.
|
PE Ratio range over the past 10 years
Min: 1.87, Med: 76.73, Max: 185.25
Current: 34.64
|
| PE Ratio without NRI | 34.64 |
PE without NRI ranked
lower than
93.30%
of
179
companies
in the
Medical Devices
industry.
Industry Max: 8940, Med: 30.17, Min: 0.06
INGN:
34.64
Ranked among companies with meaningful PE without NRI only.
|
PE without NRI range over the past 10 years
Min: 1.87, Med: 76.73, Max: 185.25
Current: 34.64
|
| Price-to-Owner-Earnings | 725.72 |
Price-to-Owner-Earnings ranked
lower than
92.31%
of
104
companies
in the
Medical Devices
industry.
Industry Max: 10850, Med: 32.03, Min: 0.73
INGN:
725.72
Ranked among companies with meaningful Price-to-Owner-Earnings only.
|
Price-to-Owner-Earnings range over the past 10 years
Min: 130.17, Med: 211.23, Max: 1091.53
Current: 725.72
|
| PB Ratio | 4.82 |
PB Ratio ranked
lower than
91.29%
of
310
companies
in the
Medical Devices
industry.
Industry Max: 1180, Med: 3.06, Min: 0.07
INGN:
4.82
Ranked among companies with meaningful PB Ratio only.
|
PB Ratio range over the past 10 years
Min: 2.39, Med: 7.31, Max: 21.16
Current: 4.82
|
| PS Ratio | 4.36 |
PS Ratio ranked
lower than
80.95%
of
294
companies
in the
Medical Devices
industry.
Industry Max: 1136.36, Med: 3.15, Min: 0.05
INGN:
4.36
Ranked among companies with meaningful PS Ratio only.
|
PS Ratio range over the past 10 years
Min: 2.35, Med: 6.57, Max: 19.07
Current: 4.36
|
| Price-to-Free-Cash-Flow | 46.12 |
Price-to-Free-Cash-Flow ranked
lower than
74.77%
of
107
companies
in the
Medical Devices
industry.
Industry Max: 3239, Med: 26.44, Min: 5.07
INGN:
46.12
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
|
Price-to-Free-Cash-Flow range over the past 10 years
Min: 24.33, Med: 56.39, Max: 222.06
Current: 46.12
|
| Price-to-Operating-Cash-Flow | 34.92 |
Price-to-Operating-Cash-Flow ranked
lower than
81.10%
of
127
companies
in the
Medical Devices
industry.
Industry Max: 1586.78, Med: 20.01, Min: 3.03
INGN:
34.92
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
|
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 16.35, Med: 41.37, Max: 104.55
Current: 34.92
|
| EV-to-EBIT | 36.08 |
EV-to-EBIT ranked
lower than
92.53%
of
174
companies
in the
Medical Devices
industry.
Industry Max: 18456.56, Med: 24.76, Min: 0.63
INGN:
36.08
Ranked among companies with meaningful EV-to-EBIT only.
|
EV-to-EBIT range over the past 10 years
Min: 16.2, Med: 60, Max: 153.2
Current: 36.08
|
| EV-to-EBITDA | 27.72 |
EV-to-EBITDA ranked
lower than
92.02%
of
188
companies
in the
Medical Devices
industry.
Industry Max: 18456.56, Med: 18.14, Min: 0.62
INGN:
27.72
Ranked among companies with meaningful EV-to-EBITDA only.
|
EV-to-EBITDA range over the past 10 years
Min: 5.7, Med: 34.75, Max: 119.1
Current: 27.72
|
| EV-to-Revenue | 3.63 |
EV-to-Revenue ranked
lower than
75.08%
of
309
companies
in the
Medical Devices
industry.
Industry Max: 17078.6, Med: 3.73, Min: 0.05
INGN:
3.63
Ranked among companies with meaningful EV-to-Revenue only.
|
EV-to-Revenue range over the past 10 years
Min: 1, Med: 6.1, Max: 18.6
Current: 3.63
|
| PEG Ratio | 1.50 |
PEG Ratio ranked
lower than
100.00%
of
77
companies
in the
Medical Devices
industry.
Industry Max: 804, Med: 2.53, Min: 0.14
INGN:
1.5
Ranked among companies with meaningful PEG Ratio only.
|
PEG Ratio range over the past 10 years
Min: 1.5, Med: 3.69, Max: 7.6
Current: 1.5
|
| Current Ratio | 7.35 |
Current Ratio ranked
higher than
87.35%
of
324
companies
in the
Medical Devices
industry.
Industry Max: 563.8, Med: 2.71, Min: 0.03
INGN:
7.35
Ranked among companies with meaningful Current Ratio only.
|
Current Ratio range over the past 10 years
Min: 1.14, Med: 5.16, Max: 7.35
Current: 7.35
|
| Quick Ratio | 6.70 |
Quick Ratio ranked
higher than
88.89%
of
324
companies
in the
Medical Devices
industry.
Industry Max: 563.8, Med: 2.03, Min: 0.02
INGN:
6.7
Ranked among companies with meaningful Quick Ratio only.
|
Quick Ratio range over the past 10 years
Min: 0.96, Med: 4.68, Max: 6.7
Current: 6.7
|
| Days Inventory | 54.31 |
Days Inventory ranked
higher than
87.07%
of
294
companies
in the
Medical Devices
industry.
Industry Max: 990.33, Med: 143.61, Min: 0.63
INGN:
54.31
Ranked among companies with meaningful Days Inventory only.
|
Days Inventory range over the past 10 years
Min: 35.87, Med: 40.68, Max: 54.31
Current: 54.31
|
| Days Sales Outstanding | 41.05 |
Days Sales Outstanding ranked
higher than
83.70%
of
276
companies
in the
Medical Devices
industry.
Industry Max: 907.73, Med: 69.21, Min: 0.13
INGN:
41.05
Ranked among companies with meaningful Days Sales Outstanding only.
|
Days Sales Outstanding range over the past 10 years
Min: 37.75, Med: 50.78, Max: 62.76
Current: 41.05
|
| Days Payable | 28.76 |
Days Payable ranked
lower than
80.08%
of
261
companies
in the
Medical Devices
industry.
Industry Max: 912.5, Med: 58.34, Min: 1
INGN:
28.76
Ranked among companies with meaningful Days Payable only.
|
Days Payable range over the past 10 years
Min: 19.85, Med: 37.91, Max: 131.45
Current: 28.76
|
Dividend & Buy Back
| Current | vs industry | vs history | |
|---|---|---|---|
| 3-Year Share Buyback Rate | -4.40 |
3-Year Share Buyback Rate ranked
higher than
53.69%
of
244
companies
in the
Medical Devices
industry.
Industry Max: 19.2, Med: -5.7, Min: -1393.3
INGN:
-4.4
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
|
3-Year Share Buyback Rate range over the past 10 years
Min: -6.6, Med: -4.4, Max: -3.3
Current: -4.4
|
Valuation & Return
| Current | vs industry | vs history | |
|---|---|---|---|
| Price-to-Tangible-Book | 5.07 |
Price-to-Tangible-Book ranked
lower than
83.33%
of
276
companies
in the
Medical Devices
industry.
Industry Max: 1180, Med: 4.5, Min: 0.07
INGN:
5.07
Ranked among companies with meaningful Price-to-Tangible-Book only.
|
Price-to-Tangible-Book range over the past 10 years
Min: 2.79, Med: 7.33, Max: 18.42
Current: 5.07
|
| Price-to-Projected-FCF | 2.67 |
Price-to-Intrinsic-Value-Projected-FCF ranked
lower than
100.00%
of
121
companies
in the
Medical Devices
industry.
Industry Max: 89.64, Med: 2.44, Min: 0.43
INGN:
2.67
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
|
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 2.34, Med: 7.35, Max: 10.44
Current: 2.67
|
| Price-to-Median-PS-Value | 0.66 |
Price-to-Median-PS-Value ranked
lower than
84.39%
of
237
companies
in the
Medical Devices
industry.
Industry Max: 20.13, Med: 1.02, Min: 0.02
INGN:
0.66
Ranked among companies with meaningful Price-to-Median-PS-Value only.
|
Price-to-Median-PS-Value range over the past 10 years
Min: 0.42, Med: 1.02, Max: 2.48
Current: 0.66
|
| Price-to-Peter-Lynch-Fair-Value | 2.11 |
Price-to-Peter-Lynch-Fair-Value ranked
lower than
100.00%
of
47
companies
in the
Medical Devices
industry.
Industry Max: 26.18, Med: 2.05, Min: 0.43
INGN:
2.11
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
|
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 1.85, Med: 4.1, Max: 6.35
Current: 2.11
|
| Price-to-Graham-Number | 2.79 |
Price-to-Graham-Number ranked
lower than
93.98%
of
133
companies
in the
Medical Devices
industry.
Industry Max: 59.6, Med: 2.11, Min: 0.06
INGN:
2.79
Ranked among companies with meaningful Price-to-Graham-Number only.
|
Price-to-Graham-Number range over the past 10 years
Min: 0.52, Med: 4.79, Max: 10.45
Current: 2.79
|
| Earnings Yield (Joel Greenblatt) % | 2.74 |
Earnings Yield (Greenblatt) ranked
higher than
52.11%
of
332
companies
in the
Medical Devices
industry.
Industry Max: 158.73, Med: 0.74, Min: -2500
INGN:
2.74
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
|
Earnings Yield (Greenblatt) range over the past 10 years
Min: 0.7, Med: 1.7, Max: 6.2
Current: 2.74
|
| Forward Rate of Return (Yacktman) % | 18.04 |
Forward Rate of Return ranked
lower than
100.00%
of
125
companies
in the
Medical Devices
industry.
Industry Max: 78.28, Med: 6.6, Min: -76.71
INGN:
18.04
Ranked among companies with meaningful Forward Rate of Return only.
|
Forward Rate of Return range over the past 10 years
Min: 17.5, Med: 20.4, Max: 20.8
Current: 18.04
|
More Statistics
| Revenue (TTM) (Mil) $ | 369.26 |
| EPS (TTM) $ | 2.06 |
| Beta | 2.14 |
| Volatility % | 66.97 |
| 52-Week Range $ | 62.32 - 287.79 |
| Shares Outstanding (Mil) | 21.93 |
Analyst Estimate
Piotroski F-Score Details
| Piotroski F-Score | 7 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA yoy | Y |
| CFROA > ROA | N |
| Lower Leverage yoy | Y |
| Higher Current Ratio yoy | Y |
| Less Shares Outstanding yoy | N |
| Higher Gross Margin yoy | Y |
| Higher Asset Turnover yoy | Y |